| Literature DB >> 30706023 |
Abstract
PURPOSE: Hospitals traditionally focus on reactive risk management such as incident reporting, but prospective risk management systems such as failure modes and effects analysis are also important tools to reduce risks and improve the safety culture. In 2015, the St George Cancer Care Centre (STGCCC) developed a multidisciplinary risk-based system for the safe and effective implementation of new technologies and techniques, using risk and benefit balance impact templates (RABBIT) developed in-house. The purpose of this study was to determine whether risk management and the safety culture in radiation oncology were perceived to have improved since the introduction of the RABBIT system. METHODS AND MATERIALS: In 2017, radiation oncologists, radiation therapists, and medical physicists were asked to rate the department before and after the introduction of the RABBIT using questions from the American Association of Physicists in Medicine Safety Profile Assessment (SPA) tool. Answers relating to the implementation of new technology/techniques are presented.Entities:
Year: 2018 PMID: 30706023 PMCID: PMC6349626 DOI: 10.1016/j.adro.2018.08.015
Source DB: PubMed Journal: Adv Radiat Oncol ISSN: 2452-1094
Figure 1Risk and benefit balance impact template methodology for implementing new medical technologies and techniques.
AAPM SPA questions used in the local survey, world average scores (October 2017), local pre- and post-RABBIT scores, and change due to RABBIT
| SPA # | 1 = Never/strongly disagree | World average (October 2017) | Local pre-RABBIT average | Local post-RABBIT average | Change due to RABBIT | |
|---|---|---|---|---|---|---|
| 10 | The clinical staff from different disciplines work well together as a team. | 4 | 3.5 | 3.9 | +0.4 | .012 |
| 26a | Pre-clinical commissioning is performed for the following systems: Treatment planning systems. | 4 | 4.4 | 4.8 | +0.4 | .008 |
| 26b | Pre-clinical commissioning is performed for the following systems: Treatment delivery systems. | 4 | 4.8 | 4.9 | +0.1 | .165 |
| 26c | Pre-clinical commissioning is performed for the following systems: Treatment management system. | 4 | 4.5 | 4.7 | +0.2 | .082 |
| 34 | When implementing major new equipment or process changes, staff are provided with sufficient training to ensure competency prior to clinical implementation. | 3 | 3.6 | 4.2 | +0.6 | .003 |
| 36 | Commissioning results are documented prior to clinical implementation. | 4 | 3.9 | 4.4 | +0.5 | .008 |
| 37 | Treatment processes are documented prior to clinical implementation. | 3 | 3.5 | 4.1 | +0.6 | .003 |
| 38 | An independent review of commissioning results is performed prior to implementation of new clinical systems and processes. | 3 | 3.2 | 3.8 | +0.6 | .002 |
| 39 | Potential risks associated with the introduction of new clinical systems and processes are assessed prior to implementation. | 3 | 3.5 | 4.6 | +1.1 | <.001 |
| 41 | An end-to-end test is performed prior to implementation of new or upgraded clinical systems and processes. | 3 | 3.9 | 4.6 | +0.7 | <.001 |
Abbreviations: AAPM = American Association of Physicists in Medicine; RABBIT = Risk and Benefit Balance Impact Template; SPA = Safety Profile Assessment.
Figure 2Pre- and post-risk and benefit balance impact template survey results for the 10 Safety Profile Assessment questions used in the survey. The arrow indicates the average result for all institutions that have participated in the survey as of October 2017.